Summary
In a population of 110 primary breast cancers with medullary features, registered in the Danish Breast Cancer Cooperative Group (DBCG) from 1977-82, we have determined ploidy and S-phase fraction (SF) by flow cytometry (FCM) on paraffin embedded tumour tissue. The distribution of DNA ploidy is not different from the distribution described for breast cancers in general. No difference is found between the subgroups of medullary and non-medullary cancer when using a new simplified histopathological definition of medullary carcinoma of the breast, recently proposed by us. When using the definition proposed by Ridolfiet al. in 1977, we find significantly more tumours with aneuploidy and high SF in the groups of typical medullary carcinoma (TMC) and atypical medullary carcinoma (AMC) than in the small group of non-medullary carcinoma (NMC), which seems a paradox, as patients with NMC have the worst prognosis. However, the number of patients in the NMC group is very small, and the percentage of aneuploid tumours is very low. In 84 protocolled patients we found no statistically prognostic importance of ploidy or SF, either in the whole group assessed or when stratifying for the histopathological subgroups. However, a prognostic influence of SF can be traced for the non-medullary cancers, according to the new definition, but not for the medullary cancers of the breast. The result emphasizes the impression of MC as being biologically different from other histological types of breast cancer.
This is a preview of subscription content, access via your institution.
References
Pedersen L, Holck S, Schiødt T: Medullary carcinoma of the breast. Cancer Treat Rev 15: 53–63, 1988
Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V: Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow-up. Cancer 40: 1365–1385, 1977
Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, Travagli JP, Gadenne C, Friedman S: Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 61: 2503–2510, 1988
Wargotz ES, Silverberg SG: Medullary carcinoma of the breast: A clinicopathologic study with appraisal of current diagnostic criteria. Hum Pathol 19: 1340–1346, 1988
Visscher DW, Zarbo RJ, Greenawald KA, Crissman JD: Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Pathol Annu 25 Pt 1: 171–210, 1990
Tubiana M, Koscielny S: Cell kinetics, growth rate and the natural history of breast cancer. The Heuson Memorial Lecture. Eur J Cancer Clin Oncol 24: 9–14, 1988
Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333–1335, 1983
Schutte B, Reynders MMJ, Bosman FT, Blijham GH: Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6: 26–30, 1985
Pedersen L, Zedeler K, Holck S, Schiødt T, Mouridsen HT: Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features. Br J Cancer 63: 591–595, 1991
Pedersen L, Holck S, Schiødt T, Zedeler K, Mouridsen HT: Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications. Breast Cancer Res Treat 14: 91–99, 1989
Pedersen L, Schiødt T, Holck S, Zedeler K: The prognostic importance of syncytial growth pattern in medullary carcinoma of the breast. APMIS 98: 921–926, 1990
Andersen KW, Mouridsen HT, Castberg Th, Fischerman K, Andersen J, Hou-Jensen K, Brincker H, Johansen H, Henriksen E, Rørth M, Rossing N: Organization of the Danish Adjuvant Trials in Breast Cancer. Dan Med Bull 28: 102–106, 1981
Lykkesfeldt AE, Balslev I, Christensen IJ, Larsen JK, Mølgaard H, Rasmussen BB, Thorpe S, Rose C: DNA ploidy and S-phase fraction in primary breast tumours in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease. Acta Oncol 27: 749–756, 1988
Vindeløv LL, Christensen IJ: A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 11: 753–770, 1990
Larsen JK, Munch-Petersen B, Christiansen J, Jørgensen K: Flow cytometric discrimination of mitotic cells: Resolution of M, as well as G1, S, and G2 phase nuclei with mithramycin, propidium iodide, and ethidium bromide after fixation with formaldehyde. Cytometry 7: 54–63, 1986
Christensen I, Hartmann NR, Keiding N, Larsen JK, Noer H, Vindeløv L: Statistical analysis of DNA distributions from cell populations with partial synchrony. In: Lutz D (ed) Pulse-Cytophotometry III. European Press, Ghent, 1978, pp 519–526
Kallioniemi O-P: Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 9: 164–169, 1988
Hedley DW: Flow cytometry using paraffin-embedded tissue: Five years on. Cytometry 10: 229–241, 1989
Alanen KA, Klemi PJ, Joenssuu H, Kujari H, Pekkala E: Comparison of fresh, ethanol-preserved, and paraffin-embedded samples in DNA flow cytometry. Cytometry 10: 81–85, 1989
Alanen KA, Joenssuu H, Klemi PJ: Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms. Cytometry 10: 417–425, 1989
Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC, and cooperating investigators: The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol no. 4). Cancer 36: 1–84, 1975
Atkin NB: Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Br Med J 1: 271–272, 1972
Atkin NB, Kay R: Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br J Cancer 40: 210–221, 1979
Auer GU, Caspersson TO, Wallgren AS: DNA content and survival in mammary carcinoma. Anal Quant Cytol 2: 161–165, 1980
Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D: Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res 44: 4187–4196, 1984
Cornelisse CJ, van de Velde CJH, Caspers RJC, Moolenaar AJ, Hermans J: DNA ploidy and survival in breast cancer patients. Cytometry 8: 225–234, 1987
Dowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blamey RW: Prognostic significance of the DNA content of human breast cancer. Br J Surg 74: 133–136, 1987
Hedley DW, Rugg CA, Ng ABP, Taylor IW: Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 44: 5395–5398, 1984
Hedley DW, Friedlander ML, Taylor IW: Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 6: 327–333, 1985
Hedley DW, Rugg CA, Gelber RD: Association of DNA Index and S-phase fraction with prognosis of node positive early breast cancer. Cancer Res 47: 4729–4735, 1987
Kallioniemi O-P, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Koivula T: Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 56: 637–642, 1987
Beerman H, Kluin PM, Hermans J, van de Velde CJ, Cornelisse CJ: Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 45: 34–39, 1990
Uyterlinde AM, Baak JP, Schipper NW, Peterse H, Matze E, Meijer CJ: Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int J Cancer 45: 1–7, 1990
Toikkanen S, Joenssuu H, Klemi P: The prognostic significance of nuclear DNA content in invasive breast cancer - a study with long-term follow-up. Br J Cancer 60: 693–700, 1989
von Rosen A, Rutqvist LE, Carstensen J, Fallenius A, Skoog L, Auer G: Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content. Breast Cancer Res Treat 13: 23–32, 1989
Keyhani-Rofagha S, O'Toole RV, Farrar WB, Sickle-Santanello B, DeCenzo J, Young D: Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma? Cancer 65: 1577–1582, 1990
McDivitt RW, Stone KR, Craig RB, Meyer JS: A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling. Lab Invest 52: 287–291, 1985
McGuire WL: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5–9, 1987
Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420–427, 1988
Eskelinen M, Nordling S, Puittinen J, Pesonen E, Collan Y: The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer. Pathol Res Pract 185: 694–697, 1989
Eskelinen MJ, Pajarinen P, Collan Y, Pesonen E, Alhava E, Kettunen K, Nordling S: Relationship between DNA ploidy and survival in patients with primary breast cancer. Br J Surg 76: 830–834, 1989
Kallioniemi O-P, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T: Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 23: 277–283, 1987
Ewers S-B, Langström E, Baldetorp B, Killander D: Flowcytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 5: 408–419, 1984
Friedlander ML, Hedley DW, Taylor IW: Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 37: 961–974, 1984
Cornelisse CJ, de Koning HR, Moolenaar AJ, van de Velde CJ, Ploem JS: Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement. Anal Quant Cytol 6: 9–18, 1984
Jakobsen A, Poulsen HS, Madsen EL, Petersen SE, Hansen HS: Ploidy level of human breast carcinoma. Acta Radiol [Oncol] 23: 103–107, 1984
Owainati AAR, Robins RA, Hinton C, Ellis IO, Dowle CS, Ferry B, Elston CW, Blamey RW, Baldwin RW: Tumour aneuploidy prognostic parameters and survival in primary breast cancer. Br J Cancer 55: 449–454, 1987
Erhardt K, Auer G, Folin A, Silfverswärd C, Skoog L: Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma. Am J Clin Oncol 9: 83–89, 1986
Olszewski W, Darzynkiewicz Z, Rosen PP, Schwartz MK, Melamed MR: Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer 48: 985–988, 1981
Olszewski W, Darzynkiewicz Z, Rosen PP, Schwartz MK, Melamed MR: Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer 48: 980–984, 1981
Moran RE, Black MM, Alpert L, Strauss MJ: Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Cancer 54: 1586–1590, 1984
Horsfall DJ, Tilley WD, Orell SR, Marshall VR, Cant ELM: Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. Br J Cancer 53: 23–28, 1986
McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC: A proposed classification of breast cancer based on kinetic information. Derived from a comparison of risk factors in 168 primary operable breast cancers. Cancer 57: 269–276, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pedersen, L., Larsen, J.K., Christensen, I.J. et al. DNA ploidy and S-phase fraction in medullary carcinoma of the breast -a flow cytometric analysis using archival material. Breast Cancer Res Tr 29, 297–306 (1994). https://doi.org/10.1007/BF00666484
Issue Date:
DOI: https://doi.org/10.1007/BF00666484